beta-Actin (13E5) Rabbit Monoclonal Anti…

The University of Nebraska Medical Center (UNMC), a state agency in Nebraska, awarded a purchase order (PO #4800230154) to Cell Signaling Technology Inc., a vendor based in Boston, Massachusetts, for the acquisition of laboratory research materials. The contract, valued at $348, was executed on September 1, 2026, with a completion deadline of October 6, 2026. The specific deliverable consists of one unit of beta-Actin (13E5) Rabbit Monoclonal Antibody (material number 4970S) at a unit price of $348.00, to be used in immunological and protein research applications.

The product will be delivered to UNMC General Supply located at 601 South Saddle Creek Road, Omaha, Nebraska, under free on board (F.O.B.) destination terms with freight prepaid by the vendor. Payment will be rendered via Nebraska State Treasury warrant under Net 30 payment terms, in accordance with the Standard Terms of Purchase established by the University of Nebraska Board of Regents. The vendor is required to acknowledge acceptance of the purchase order within ten days of the order date, with all packages, invoices, and related documentation bearing the purchase order number.